Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

10-16-2018 | Metabolic surgery | medwireNews | News

Marked reduction in vascular events in diabetes patients after bariatric surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

09-26-2018 | Insulin | View from the clinic | Collection

Four steps I take when starting patients on insulin

Editorial Board member Jay Shubrook succinctly delivers his strategies for initiating insulin therapy for the first time in patients with type 2 diabetes.

09-30-2018 | UKPDS | Feature | Article

The UKPDS: A lasting legacy

Twenty years after the publication of the primary findings, medwireNews talks to longtime UKPDS investigator Professor David Matthews (University of Oxford, UK) about the struggles of the team to bring the trial to completion and the impact of the findings on diabetes care.

Latest from across the site

10-18-2018 | Empagliflozin | News

News in brief

Up to 4.5 years’ life gained with SGTL2 inhibition in EMPA REG

The protective effect of empagliflozin against cardiovascular and all-cause mortality translates into between 1.0 and 4.5 years of additional life expectancy for high-risk patients with type 2 diabetes, say the EMPA REG OUTCOME investigators.

10-17-2018 | Liraglutide (T2DM) | News

Cardiovascular benefits of liraglutide in type 2 diabetes apply to high-risk subgroups

The cardioprotective effects of liraglutide apply to patients with chronic kidney disease as well as those with established cardiovascular disease, show two post-hoc analyses of the LEADER trial.

Source:

Circulation 2018; doi:10.1161/CIRCULATIONAHA.118.036418
Circulation 2018; doi:10.1161/CIRCULATIONAHA.118.034516

10-16-2018 | Metabolic surgery | medwireNews | News

Marked reduction in vascular events in diabetes patients after bariatric surgery

An observational study published in JAMA demonstrates a substantial reduction in the risk for hard cardiovascular endpoints in obese patients with type 2 diabetes who have undergone bariatric surgery.

10-16-2018 | Metabolic surgery | Article

Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity

Fisher DP et al. JAMA 2018; 320: 1570–1582. doi: 10.1001/jama.2018.14619

10-15-2018 | Genetics | News

SGLT1 haplotype linked to reduced cardiometabolic risk

Researchers have identified a haplotype of three missense mutations in the sodium-glucose cotransporter-1 gene that is associated with a reduced risk for impaired glucose tolerance, diabetes, and obesity.

Source:

J Am Coll Cardiol 2018; 72: 1763–1773, 1774–1777

10-15-2018 | Statins | Review | Article

Beyond statins: Who and when to prescribe?

Ganda O. Curr Diab Rep 2018; 18: 126. doi: 10.1007/s11892-018-1087-0

medwireNews@EASD2018

The 2018 EASD Annual Meeting took place in Berlin from the 1st to 5th October. Click here for news and expert commentary, including the EASE, PREVIEW, and HARMONY trials.

Meet our Editorial Board

New Content Item Meet our Advisory Board

image credits